A Study Assessing The Effect Of A Structured Medication Review On Quality Of Life In Patients With Parkinson*s Disease*
Completed
- Conditions
- Movement DisordersParkinson's Disease10028037
- Registration Number
- NL-OMON44681
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 198
Inclusion Criteria
* Diagnosed with PD according to the UK-brain banking criteria
* * Eighteen years of age
* * Four different medications daily
* * Four medication intake moments daily
* Expressing motor symptoms or non-motor symptoms
* Living independent or semi-independent in the region of Enschede
* Be able to read and write the Dutch language
Exclusion Criteria
* Unable to take own medications, excluding PD patients with personal or family home caregivers
* Received a medication review within a year before the study
* Received a Deep Brain Stimulator within a year before the study
* Receiving continuous duodopa gastro-intestinal gel therapy or will receive this within three months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary objective of the study is to assess whether a structured medication<br /><br>review leads to better quality of life in patients with PD. Disease-specific<br /><br>quality of life will be measured, using the PDQ-39.</p><br>
- Secondary Outcome Measures
Name Time Method